Arvest Bank Trust Division’s Bristol-Myers Squibb BMY Stock Holding History

Arvest Bank Trust Division’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$747K	Sell	12,969 -824	-6%	-$47.3K	0.04%	158
2026 Q1	$837K	Buy	13,793 +740	+6%	+$43.1K	0.05%	144
2025 Q4	$704K	Buy	13,053 +875	+7%	+$42.1K	0.04%	143
2025 Q3	$549K	Buy	12,178 +804	+7%	+$37.5K	0.03%	153
2025 Q2	$527K	Sell	11,374 -21,403	-65%	-$1.05M	0.03%	138
2025 Q1	$2M	Buy	32,777 +324	+1%	+$18.9K	0.13%	92
2024 Q4	$1.84M	Sell	32,453 -867	-3%	-$48.4K	0.11%	95
2024 Q3	$1.72M	Buy	+33,320	New	+$1.56M	0.1%	97
2021 Q3	$854K	Buy	14,440 +4,169	+41%	+$275K	0.05%	100
2021 Q2	$686K	Buy	+10,271	New	+$670K	0.04%	107

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Arvest Bank Trust Division's BMY Position: Q2 2026 in Review

Arvest Bank Trust Division reduced its Bristol-Myers Squibb (BMY) stake by 6% in Q2 2026, selling an estimated $47.3K and leaving 12,969 shares worth $747K. The position accounts for 0.04% of the portfolio, ranked #158.

Arvest Bank Trust Division first reported a position in BMY in Q2 2021 and has held it in 10 quarters since. The position peaked at $2M in Q1 2025. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Arvest Bank Trust Division held 12,969 shares of Bristol-Myers Squibb worth $747K as of Q2 2026.
Arvest Bank Trust Division sold 824 Bristol-Myers Squibb shares in Q2 2026, an estimated $47.3K.
Bristol-Myers Squibb made up 0.04% of Arvest Bank Trust Division's portfolio in Q2 2026, its #158 holding.
Arvest Bank Trust Division first reported a position in Bristol-Myers Squibb in Q2 2021 and has held it in 10 quarters since.
Arvest Bank Trust Division's Bristol-Myers Squibb position peaked at $2M in Q1 2025.
2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Arvest Bank Trust Division's 13F filing for Q2 2026, filed 13 Aug 2026.